{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:55:13Z","timestamp":1793163313278,"version":"4.5.0"},"reference-count":114,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","award":["33799\/DIDIT\/2023"],"award-info":[{"award-number":["33799\/DIDIT\/2023"]}],"id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune\u2010mediated inflammatory disease (IMID) patients including psoriasis, inflammatory arthritides and bowel diseases have a higher risk of developing cardiovascular (CV) diseases compared to the general population. The increased CV risk may be promoted by tumour necrosis factor (TNF)\u2010\u03b1\u2010mediated immunological processes, which are present both in the pathomechanism of IMIDs and atherosclerosis. Our objective was to comprehensively investigate the effect of TNF inhibitors (TNFi) on CV risk compared with conventional therapies in IMIDs. The systematic literature search was conducted in three databases (MEDLINE, EMBASE, Cochrane Library) on 14 November 2022. Randomized controlled trials, cohort and case\u2013control studies were eligible for inclusion. Outcomes consisted of the incidence of CV events, with major adverse cardiovascular events (MACE) as a main endpoint. A random\u2010effects meta\u2010analysis was performed by pooling fully adjusted multivariate hazard ratios (HR) and incidence rate ratios (IRR) with a 95% confidence interval (CI) comparing TNFis with conventional systemic non\u2010biologicals (CSNBs). Of a total of 8724 search results, 56 studies were included overall, of which 29 articles were eligible for the meta\u2010analysis, and 27 were involved in the systematic review. Including all IMIDs, the TNFi group showed a significantly reduced risk of MACE compared with the CSNB group (HR\u2009=\u20090.74, 95% confidence interval (CI) 0.58\u20130.95, <jats:italic>p<\/jats:italic>\u2009=\u20090.025; IRR\u2009=\u20090.77, 95% CI 0.67\u20130.88, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Subgroup analysis of Pso, PsA patients by pooling IRRs also confirmed the significantly decreased risk of MACE in TNFi\u2010treated patients compared with CSNB groups (IRR\u2009=\u20090.79, 95% CI 0.64\u20130.98). The observational nature of most included studies leading to high heterogeneity represents a limitation. Based on the results, TNFis may reduce the risk of CV events compared to CSNBs. Therefore, earlier use of TNFis compared to conventional systemic agents in the therapeutic sequence may benefit CV risk in IMID patients.<\/jats:p>","DOI":"10.1111\/jdv.19900","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T07:09:05Z","timestamp":1709536145000},"page":"1070-1088","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reducing cardiovascular risk in immune\u2010mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies\u2014A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3178-5873","authenticated-orcid":false,"given":"N. \u00c1.","family":"Galajda","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-6838","authenticated-orcid":false,"given":"F. A.","family":"Meznerics","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5144-0733","authenticated-orcid":false,"given":"P.","family":"M\u00e1trai","sequence":"additional","affiliation":[{"name":"Institute for Translational Medicine, Medical School University of P\u00e9cs  P\u00e9cs Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-018X","authenticated-orcid":false,"given":"P.","family":"Feh\u00e9rv\u00e1ri","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"},{"name":"Department of Biostatistics University of Veterinary Medicine  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3280-4181","authenticated-orcid":false,"given":"A. S.","family":"Lengyel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"},{"name":"HCEMM\u2010SU Translational Dermatology Research Group, Department of Physiology Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8043-9391","authenticated-orcid":false,"given":"M. V.","family":"Kolonics","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7845-8116","authenticated-orcid":false,"given":"Z.","family":"Sipos","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-1844","authenticated-orcid":false,"given":"L. V.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"},{"name":"HCEMM\u2010SU Translational Dermatology Research Group, Department of Physiology Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-3333","authenticated-orcid":false,"given":"D.","family":"Csupor","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"},{"name":"Institute of Clinical Pharmacy, Faculty of Pharmacy University of Szeged  Szeged Hungary"},{"name":"Institute for Translational Medicine, Medical School University of P\u00e9cs  P\u00e9cs Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0399-7259","authenticated-orcid":false,"given":"P.","family":"Hegyi","sequence":"additional","affiliation":[{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"},{"name":"Institute for Translational Medicine, Medical School University of P\u00e9cs  P\u00e9cs Hungary"},{"name":"Institute of Pancreatic Diseases Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-1364","authenticated-orcid":false,"given":"A.","family":"B\u00e1nv\u00f6lgyi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"},{"name":"Centre for Translational Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-8989","authenticated-orcid":false,"given":"P.","family":"Holl\u00f3","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine Semmelweis University  Budapest Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,3]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1909094"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204021"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.10.031"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224434"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31827f27ae"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-316378"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226812"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1315-z"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp567"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314015"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102925"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.02.042"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.829709"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13970"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30221-6"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc0902.104353"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.57"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20371"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8560-9"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23875"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223302"},{"key":"e_1_2_12_24_1","unstructured":"HigginsJPTTJ ChandlerJ CumpstonM LiT PageMJ WelchVA.Cochrane Handbook for Systematic Reviews of Interventions version 6.3.2022Available at:www.training.cochrane.org\/handbook. Last accessed 25 Sep 2023."},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.3.014"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_2_12_28_1","unstructured":"RohatgiA.WebPlotDigitizer.2022Available at:https:\/\/automeris.io\/WebPlotDigitizer. Last accessed 25 Sep 2023."},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h870"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1482"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_12_34_1","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2020"},{"key":"e_1_2_12_35_1","volume-title":"Meta: general package for meta\u2010analysis","author":"Schwarzer G.","year":"2022"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10525.x"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12768"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2010.09.005"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22166"},{"key":"e_1_2_12_40_1","first-page":"1002","article-title":"Evaluation of risk of major adverse cardiovascular events with biologic therapy in patients with psoriasis","volume":"16","author":"Bissonnette R","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.067660"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211032444"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211030809"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218510"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/247553031600100307"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131464"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22809"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100347"},{"key":"e_1_2_12_49_1","first-page":"1441","article-title":"Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies","volume":"13","author":"Gottlieb AB","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129916"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/17-101"},{"key":"e_1_2_12_52_1","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson LT","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318932"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02836-4"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.08.032"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1669-x"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.479"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4584"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30654"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39582"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209784"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27660"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211209"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1077-z"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket333"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23935"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2383"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200265"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa683"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab522"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1593-8"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16018"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2021.06.008"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1254145"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22255"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.016"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23609"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-021-00207-1"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22094"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000535"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4037-y"},{"key":"e_1_2_12_82_1","first-page":"1211","article-title":"Adverse medical conditions across treatment options in patients with psoriasis: a claims\u2010based analysis","volume":"17","author":"Wu JJ","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.042"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14951"},{"key":"e_1_2_12_85_1","first-page":"932","article-title":"Tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis, psoriatic arthritis, or both","volume":"13","author":"Wu JJ","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_86_1","first-page":"899","article-title":"Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"12","author":"Wu JJ","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.2502"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.050"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5546"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000080"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23811"},{"key":"e_1_2_12_92_1","first-page":"566","article-title":"Evaluation of risk of major adverse cardiovascular events with biologic therapy in patients with psoriasis (errata)","volume":"19","author":"Bissonnette R","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_93_1","first-page":"573","article-title":"Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies errata","volume":"19","author":"Gottlieb AB","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.977"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-00189-0"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25009"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.06.112"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.019"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.5.484"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7712587"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.928471"},{"key":"e_1_2_12_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16926"},{"key":"e_1_2_12_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz180"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab178"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/life11090919"},{"key":"e_1_2_12_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.042"},{"key":"e_1_2_12_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.2977"},{"key":"e_1_2_12_111_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead072"},{"key":"e_1_2_12_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19356"},{"key":"e_1_2_12_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15581"},{"key":"e_1_2_12_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01458-8"},{"key":"e_1_2_12_115_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051532"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.19900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:21:03Z","timestamp":1716672063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.19900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,3]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1111\/jdv.19900"],"URL":"https:\/\/doi.org\/10.1111\/jdv.19900","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,3]]},"assertion":[{"value":"2023-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}